Patents matching “SION”

US 7056908

Pharmaceutical compositions and methods for preventing skin tumor formation and causing regression of existing tumors

The United States of America, as represented by the Department of Health and Human Services · Granted Jun 6, 2006 · Expires Jun 1, 2026

US 7056741

Surface transfection and expression procedure

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 6, 2006 · Expires Jun 1, 2026

US 7052829

Prevascularized constructs for implantation to provide blood perfusion

Arizona Board of Regents on Behalf of the University of Arizona · Granted May 30, 2006 · Expires May 25, 2026

US 7053263

Mouse models of human prostate cancer progression

The Regents of the University of California · Granted May 30, 2006 · Expires May 25, 2026

US 7053125

Controlled dispersion of colloidal suspension by comb polymers

W.R. Grace & Co.-Conn. · Granted May 30, 2006 · Expires May 25, 2026

US 7052695

Angiopoietins and methods of treating hypertension

REGENERON PHARMACEUTICALS, INC. · Granted May 30, 2006 · Expires May 25, 2026

EP 1655027

Verwendung von 9-(N-methyl-piperidyliden-4)-thioxanthene zur Behandlung von pulmoler Hypertension und Migräne

BIOFRONTERA PHARMACEUTICALS GM [DE] · Granted May 10, 2006 · Expires May 5, 2026

US 7037680

Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy

The United States of America as represented by the Secretary of the Army · Granted May 2, 2006 · Expires Apr 27, 2026

US 7029838

Prevascularized contructs for implantation to provide blood perfusion

Arizona Board of Regents on Behalf of the University of Arizona · Granted Apr 18, 2006 · Expires Apr 13, 2026

US 7013219

Regulation of endogenous gene expression in cells using zinc finger proteins

Sangamo Biosciences, Inc. · Granted Mar 14, 2006 · Expires Mar 9, 2026

US 6998513

Human inflammatory breast carcinoma xenograft capable of lymphovascular invasion and methods for its use

The Regents of the University of California · Granted Feb 14, 2006 · Expires Feb 9, 2026

US 6992096

1,2,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease

PTC THERAPEUTICS, INC. · Granted Jan 31, 2006 · Expires Jan 26, 2026

US 6989375

Enhanced expression of transgenes

The Board of Regents of the University of Texas System · Granted Jan 24, 2006 · Expires Jan 19, 2026

US 6984388

Adhesion deficient isolate of Flavobacterium columnare against columnaris disease

The United States of America, as represented by the Secretary of Agriculture · Granted Jan 10, 2006 · Expires Jan 5, 2026

US 6979539

Regulation of endogenous gene expression in cells using zinc finger proteins

Sangamo Biosciences, Inc. · Granted Dec 27, 2005 · Expires Dec 22, 2025

US 6977244

Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides

The Board of Regents of the University of Texas System · Granted Dec 20, 2005 · Expires Dec 15, 2025

US 6977272

Method for antagonizing inhibition effects of alcohol on cell adhesion

United States Department of Veteran Affairs · Granted Dec 20, 2005 · Expires Dec 15, 2025

US 6956145

Mice models of human prostate cancer progression

The Regents of the University of California · Granted Oct 18, 2005 · Expires Oct 13, 2025

US 6951743

Hyaluronan synthase genes and expression thereof in bacillus hosts

University of Oklahoma Board of Regents · Granted Oct 4, 2005 · Expires Sep 29, 2025

US 6949690

Methods of assessing the effect of a gene of interest on human prostate cancer progression

The Regents of the University of California · Granted Sep 27, 2005 · Expires Sep 22, 2025

US 6942663

Laser treatment of cutaneous vascular lesions

The Board of Regents of the University of Texas System · Granted Sep 13, 2005 · Expires Sep 8, 2025

US 6933129

Method for culturing and assaying cells

Precision Therapeutics, Inc. · Granted Aug 23, 2005 · Expires Aug 18, 2025

US 6933113

Modulation of endogenous gene expression in cells

Sangamo Biosciences, Inc. · Granted Aug 23, 2005 · Expires Aug 18, 2025

DE 102004006048

Pharmazeutische Kombination aus Gadolinium Komplexen und kolloidalen Biopolymeren und deren Verwendung als kontrastverstärkendes Mittel zur i.v. Injektion bzw. i.v. Infusion in der MR Angiographie

NEUROBIOTEC GMBH [DE] · Granted Aug 18, 2005 · Expires Aug 13, 2025